Shredz Core Creatine
Natural health product licensed in Canada
- Licence holder
- Shredz Supplements LLC
- NPN or DIN-HM
- 80068982
- Status
- Active licence
- Licence date
- 28 April 2016
- Revision date
- Not provided
- Form
- Capsule
- Route of administration
- Orale
- Application type
- Non traditionnelle
If this product were sold in France
No point flagged by the rules we apply.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| Chélate de créatine magnésium Source : Chélate de créatine magnésium | 250 milligramme | Not calculated |
| Acide bêta-aminopropionique Source : Beta-alanine | 250 milligramme | Not calculated |
| L-arginine Source : Alpha-cétoglutarate de L-arginine | 136 milligramme | Not calculated |
| Vanadium Source : Sulfate de vanadyle | 43.2 microgrammes | Not calculated |
Non-medicinal ingredients
Gélatine, Dioxyde de titane, Stéarate de magnésium, Extrait de Capsicum Annuum, farine de riz, dérivé sodium-cuivre de la chlorophylline
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes de sexe masculin | Not specified | 2 Capsule | 2 Tous les jours |
Uses authorised in Canada
Workout Supplement. Athletic Support. Source of an amino acid involved in muscle protein synthesis. A factor in the maintenance of good health. Mineral Supplement.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
- Précautions et mises en garde
Ensure to drink enough fluid before, during, and after exercise. Consult a health care practitioner if your cardiovascular condition worsens. Consult a health care practitioner prior to use if you have a renal/kidney disease/kidney disorder or if you are following a low protein diet. Consult a health care practitioner prior to use if you suffer from a cardiovascular disease and are attempting an increase in physical activity. Consult your health care practitioner prior to use if you are taking medication for cardiovascular diseases, erectile dysfunction, and/or blood thinners.
- Contre-indications
Do not use if you have had a heart attack/myocardial infarction.
- Effets indésirables connus
May cause a flushing, tingling and/or prickling sensation of the skin, in which case, reduce the dose. Some people may experience gastrointestinal discomfort (such as diarrhea).
Source
Official Health Canada record, licence 80068982
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.